Sartorius

Xell is an experienced partner for companies in the biotech and pharmaceutical industry providing them with highly-efficient solutions in cell culture technology. Meeting our customers’ specific needs is the objective of our dedicated team – our personal approach to challenging tasks is key to Xell’s success. With years of industry experience, we bring our extensive expertise in ultra-high performance mediaand feed development, and apply our powerful analytical tools for in-depth characterization of biological systems and pharmaceutical proteins, guaranteeing optimal solutions for our customers’ bioprocesses. At Xell, versatile experts work with our customers as one team to create customized solutions for their cell culture challenges.

They develop, manufacture and market human cytokines, growth factors, and other recombinant cell culture components in preclinical and GMP quality as well as proprietary serum-free media for further manufacturing of ATMPs. Their products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world. As an ATMP developer and manufacturer they gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background they understand the high requirements their customers face during product development and the regulatory approval process.

ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.

Danaher Life Sciences provide scientists with meaningful research tools and services to gain a better understanding of biological and chemical matters. The combined efforts of Beckman Coulter Life Sciences, SCIEX, Molecular Devices, Pall, and Leica Microsystems work synergistically to provide increasingly sophisticated technologies designed to integrate across systems faster and with more accurate data.

Umetrics is a leading specialist in data analytics software for modeling and optimizing biopharmaceutical development and manufacturing processes.

Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation. Our inventions have spanned nearly twenty years, and are recognized as “first in class” in several technology areas including optical cell-based screening (FLIPR, 1994), high through electrophysiology (IonWorks, 2002) and kinetic imaging (IncuCyte, 2006; IncuCyte ZOOM, 2012). To date, our inventions have accounted for nearly 1 billion dollars in worldwide sales.

ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission-critical processes, such as vaccine manufacturing, protein expression, antiviral development, and other settings where viruses play a significant role. It was founded in 2012 and is based in Broomfield, Colorado.

kSep Systems provides innovation, engineering, and cGMP manufacturing expertise to produce robust and automated single-use bioprocessing solutions for our clients in the areas of recombinant therapeutics, cell therapy, and vaccines manufacturing.

IntelliCyt Corporation develops and markets innovative high-throughput cell and bead-based screening solutions for use throughout the life sciences. The Company uses proprietary technologies to create instrumentation, reagent kits, and software products that dramatically increase the speed and decrease the cost of detecting and measuring cells and beads. IntelliCyt’s products address a pervasive need among pharmaceutical, biotechnology, and life science research laboratories to achieve increased productivity while adapting to the accelerating pace and increasing complexity of modern life sciences. Founded in 2006 by life science entrepreneurs and leading scientists, IntelliCyt Corporation was the first to commercialize a true high throughput screening platform for suspension cells that addresses urgent unmet needs in phenotypic small molecule drug discovery, antibody discovery, in vitro toxicology as well as other high profile research areas. By combining the sensitive, proven detection technology of flow cytometry with a patented sample processing technology, IntelliCyt’s HTFC Screening System enables suspension cell assays at speeds up to 40x faster than traditional flow cytometry. IntelliCyt has integrated HTFC with application-specific reagent kits and informatics software to address the growing market for high throughput cell based assays to provide earlier, more physiologically relevant results at lower cost.

Cellca is a highly specialised technology and service provider focussing on upstream technologies for mammalian protein manufacturing. They make mammalian protein manufacturing faster and more cost-efficient through proprietary process technologies and services. The main characteristics of their high expression technology are efficiency, robustness and scalability.